Probiotic Ingredients Market To Reach USD 497.0 Million By 2027

Probiotic Ingredients Market To Reach USD 497.0 Million By 2027

  • January 21, 2021

New York, Jan. 21, 2021 (GLOBE NEWSWIRE) — The global market for probiotic ingredients registered a grand value of USD 267.2 Million in the year 2019 and has been predicted to be worth USD 497.0 Million by 2027, growing at an 8.9% CAGR. The term ‘probiotic’ is used to name bacteria with several beneficial effects for animals as well as humans. The wide array of advantages of food with added microbes or probiotics on human health, and in specific children’s milk products and other considerable population with high-risks, are being highly encouraged by medical professionals/health experts. Probiotics can play a crucial role in digestive, immunological, and distinct respiratory functions, having a significant effect towards easing children’s infectious diseases. Many dairy products are used for probiotics. A few examples of such dairy-based products include; regular milk, buttermilk, flavored liquid milk, fermented dairy beverage, fermented milk, milk powder, yogurt drink, whey-protein-based drinks, ice cream, yogurt, sour cream, and a few probiotic cheese products.

Probiotics in different beverages help in maintaining the salt balance along with reducing dehydration by regulating the digestive juices’ flow, triggering demand in the industry. Regular consumption of beverages with probiotic aids in keeping the intestines, stomach, and colon clean, thus promoting proper digestion of various essential nutrients as well as reducing acid reflux symptoms. This factor is further contributing to the market’s growth. Additionally, the probiotic strains’ application in different fermented meat products such as ham and salami enhance the dough’s elasticity, making it suitable for stomach acids in breaking down of complex protein, easing digestion.
Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/2916

North America region accounts for a significant share in the market owing to the high occurrence of food and beverages and pharmaceutical manufacturers; leading to a great emphasis on applying several probiotic ingredients within their broad range of end products. Furthermore, high consumer awareness regarding gut diseases, and stringent government rules about the livestock conservation have further accelerated the market’s growth in the region.

Further key findings from the report suggest

  • There are ample evidences come from standard clinical trials regarding the probiotics’ beneficial effects on human health in different clinical conditions.
  • In normal circumstances, probiotics are added to foods as a part of the process of fermentation. The emphasis for prolonged probiotics’ survival in the food matrix has led to the efficacy and functionality alteration in the food product.
  • Probiotic bacteria show diverse and multiple influences on the host. Different microorganisms can influence the environment of intestinal luminal, mucosal and epithelial barrier function, and the immune system.
  • The various cell types affected by a wide range of probiotics include dendritic cells, epithelial cells, monocytes/macrophages, T cells, and B cells.
  • The probiotics’ effectiveness is related to their survival ability in the alkaline and acidic environment of gut and their adherence in the colon.
  • The Asia Pacific region has been presumed to hit USD 101.49 Million by the year 2027 in this industry. several product manufacturers are highly established in Asia Pacific.
  • The application sub-segment of probiotic dietary supplements is predicted to occupy an 8.0% CAGR during the period of 2020-2027.
  • Key market players include DowDuPont (U.S.), Kerry (Ireland), CHR. Hansen (Denmark), Biena (U.S.), Probi (Sweden), Biogaia (Sweden), Glac Biotech (Taiwan), Lallemand (Canada), Bifodan (Denmark), and UAS Laboratories (U.S.).

Buy Your Copy Now (Customized Report Delivered as per Your Specific Requirement)@ https://www.reportsanddata.com/checkout-form/2916

Segments covered in the report:

This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2017 to 2027. For the purpose of this study, Reports and Data has segmented the Probiotic Ingredients Market based on source, application, end-use, form, and region:

Source Outlook (Revenue, USD Million, 2017 – 2027)

  • Lactobacilli
  • Bifidobacterum
  • Streptococcus
  • Other Genus

Application Outlook (Revenue, USD Million, 2017 – 2027)

  • Probiotic Food & Beverages
  • Probiotic Dietary Supplements
  • Animal Feed Probiotic

End-Use Outlook (Revenue, USD Million, 2017 – 2027)

  • Human Probiotics
  • Animal Probiotics

Form Outlook (Revenue, USD Million, 2017 – 2027)

  • Dry Form
  • Liquid Form
  • Bran and fiber

Click on the link to read key highlights of the report and look at projected trends for years to come:   https://www.reportsanddata.com/report-detail/probiotic-ingredients-market

Regional Outlook (Revenue, USD Million; 2017 – 2027)

  • Germany
  • France
  • U.K.
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Rest of Asia Pacific
  • Brazil
  • Rest of Latin America

Take a Look at our Related Reports:

Agricultural Biostimulants Market Analysis By Type (Acid-based, Extract-based, Others), By Application (Soil, Foliar, Seed and Others) And Segment Forecasts, 2017-2026

Potash Fertilizers Market Share, Size & Analysis, By Product Type (Potassium Chloride, Potassium Nitrate, Sulfate of Potash), By Mode of Application (Foliar, Broadcasting, Fertigation), By Crop Type (Cereals & Grains, Fruits & Vegetables, Oilseeds & Pulses), 2017-2027

Seed Treatment Market Size, Share & Demand, By Type (Chemical Seed Treatment, Biological Seed Treatment), By Crop Type, By Application Technique, By Function And By Region, Forecasts To 2027

Biopesticides Market Size, Share & Analysis, By Product Type (Bioherbicides, Bioinsecticides, Bionematicides), By Crop Type, By Mode of Application, By Source, By Formulation, And By Region, Forecasts To 2027

Phosphate Fertilizer Market Demand, Share & Outlook, By Product Type (Superphosphate, Monoammonium Phosphate, Diammonium Phosphate), By Application, By Distribution Channel And By Region, Forecasts To 2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

LinkedIn | Twitter | Blogs

Read Full Press Release@ https://www.reportsanddata.com/press-release/global-probiotic-ingredients-market

Global Functional Beverages Market Report 2020-2030: COVID-19 Impacts, Growth and Changes

Global Functional Beverages Market Report 2020-2030: COVID-19 Impacts, Growth and Changes

  • January 7, 2021

Dublin, Jan. 07, 2021 (GLOBE NEWSWIRE) — The “Functional Beverages Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com’s offering.

Functional Beverages Global Market Opportunities and Strategies to 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global functional beverages market.

This report describes and evaluates the global functional services market. It covers 2015 to 2019, termed the historic period, and 2019 to 2023 termed the forecast period, along with further forecasts for the periods 2023-2025 and 2025-2030.

The global functional beverages market reached a value of nearly $128,660 million in 2019, having increased at a compound annual growth rate (CAGR) of 4.6% since 2015. The market is expected to decrease from $128,660 million in 2019 to $125,390 million in 2020 at a rate of -2.5%. The decline is mainly due to lockdown and social distancing norms imposed by various countries and economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 8.07% from 2021 and reach $158,280 million in 2023.

The energy drinks market was the largest segment of the functional beverages market segmented by type, accounting for 24.8% of the total in 2019. Going forward, energy drinks segment is expected to be the fastest growing segment in the functional beverages market, at a CAGR of 9.0%.

The functional beverages market is also segmented by function into health & wellness; and weight management. The health & wellness segment was the largest segment of the functional beverages market segmented by function, accounting for 80.7% of the total in 2019. Going forward, health & wellness segment is expected to be the fastest growing segment in the functional beverages market, at a CAGR of 7.6%.

The functional beverages market is also segmented by distribution channel into brick and mortar; specialty foodservice stores; and online. The brick and mortar segment was the largest segment of the functional beverages market segmented by function, accounting for 75.1% of the total in 2019. Going forward, online segment is expected to be the fastest growing segment in the functional beverages market, at a CAGR of 18.6%.

The coronavirus outbreak has given an positive impact on the global functional beverages market The disease has caused elevated health consciousness among consumers, who are increasingly look for healthy alternatives in food and beverages to boost immunity and decrease chances of contracting the virus. The demand for functional beverages has increased since the pandemic began as they offer high nutritional and health and wellness value. Substituting high sugar drinks and carbonated drinks with functional beverages has become a ‘health trend’ in 2020, and is viewed as a precautionary step towards curbing the effects of the virus. However, low sales from the off premise consumption channels such as restaurants impacted the overall sales of the market.

The functional beverages market is slightly concentrated, with a small number of large players holding significant market share. The top ten competitors in the market made up to 43.44% of the total market in 2019. Major players in the market include The Coca-Cola Company, PepsiCo Inc., Nestle S.A, Danone and Red Bull GmbH.

The top opportunities in the functional beverages market segmented by type will arise in the energy drinks market segment, which will gain $9,220.7 million of global annual sales by 2023. The functional beverages market size will gain the most in the China at $8,192.2 million.

Market-trend-based strategies for functional beverages market include investing in natural botanicals infused drinks, offering relaxation drinks to consumers to capture the market and increase revenues, offering CBD-infused drinks to attract more customers, investing in manufacturing protein-based beverages to attract fitness enthusiasts and health conscious customers, offering dairy-based functional beverages to cater to the needs of consumers who prefer natural ingredients over other elements in their drinks and introducing new vegan or plant-based portfolio of functional drinks in order to attack health-conscious consumers.

To take advantage of the opportunities, the publisher recommends companies should focus on providing immunity boosting beverages during covid-19, natural botanicals infused drinks, CBD-infused functional drinks, strategic acquisitions and product portfolio development, healthy hydration drinks, use of low-calorie natural sweeteners, competitive pricing, expanding in emerging markets, set up authorized distributors and sales representatives, leverage e-commerce to maximize reach and revenues, increase adoption of internet and social media, use direct-to-consumer (DTC) advertising, participate in trade shows and events, and targeting millennials.

Key Topics Covered:

1. Functional Beverages Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1.1. Segmentation by Geography
6.1.2. Segmentation by Function
6.1.3. Segmentation by Distribution Channel

7. Functional Beverages Market Characteristics
7.1. Market Definition
7.2. Market Segmentation by Type
7.2.1. Energy Drinks
7.2.2. Sports Drinks
7.2.3. Nutraceutical Drinks
7.2.4. Dairy-Based Beverages
7.2.5. Juices
7.2.6. Enhanced Water
7.2.7. Others
7.3. Market Segmentation by Function
7.3.1. Health and Wellness
7.3.2. Weight Management
7.4. Market Segmentation by Distribution Channel
7.4.1. Brick and Mortar
7.4.2. Specialty Foodservice Stores
7.4.3. Online

8. Functional Beverages Market Customer Information
8.1. Immune System Support is the Main Driver Behind Purchase of Functional Beverages
8.2. Many Consumers Surveyed Showed Keen Interest in Functional Beverages
8.3. There Has Been Rapid Growth in Revenues of Manufacturers Who Already Exist in the Functional Beverage Market
8.4. Protein is the most Favored Ingredient Among the Young Population, an Age Group Which Has Been Increasingly Driving the Functional Beverages Market

9. Functional Beverages Market Trends and Strategies
9.1. Natural Botanicals Infused Drinks
9.2. Relaxation Drinks
9.3. CBD-Infused Functional Drinks
9.4. Protein-Based Functional Beverages
9.5. Dairy in Functional Beverages
9.6. Vegan/ Plant-Based Functional Beverages
9.7. Healthy Hydration Drinks
9.8. Introduction of Nootropic Drinks (Brain Health)
9.9. Use of Low-calorie Natural Sweeteners
9.10. Strategic Acquisitions and Product Portfolio Development
9.11. Expanding Geographical Presence

10. COVID Impact on the Functional Beverages Market
10.1. Surveys on COVID Impact on Consumers

11. Global Functional Beverages Market Size and Growth
11.1. Market Size
11.2. Historic Market Growth, 2015 – 2019, Value ($ Million)
11.2.1. Drivers of the Market 2015 – 2019
11.2.2. Restraints on the Market 2015 – 2019
11.3. Forecast Market Growth, 2019 – 2023, 2025F, 2030F Value ($ Million)
11.3.1. Drivers of the Market 2019 – 2023
11.3.2. Restraints on the Market 2019 – 2023

12. Global Functional Beverages Market Segmentation
12.1. Global Functional Beverages Market, Segmentation by Type, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
12.1.1. Energy Drinks
12.1.2. Dairy-based Beverages
12.1.3. Sports Drinks
12.1.4. Enhanced Water
12.1.5. Nutraceutical Drinks
12.1.6. Juices
12.1.7. Others
12.2. Global Functional Beverages Market, Segmentation by Function, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
12.2.1. Health & Wellness
12.2.2. Weight Management
12.3. Global Functional Beverages Market, Segmentation by Distribution Channel, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
12.3.1. Brick and Mortar
12.3.2. Specialty Foodservice Stores

13. Functional Beverages Market, Regional and Country Analysis
13.1. Global Functional Beverages Market, by Region, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)
13.2. Global Functional Beverages Market, by Country, Historic and Forecast, 2015 – 2019, 2023F, 2025F, 2030F, Value ($ Million)

Companies Mentioned

  • Abbott
  • Amul
  • Asahi Soft Drinks Co Ltd
  • Beijing Huiyuan Food and Beverage Co., Ltd
  • Beverage Industrial Co., Ltd
  • Britannia Industries Ltd
  • Campbell Soup Company
  • China Haisheng Juice Holdings Co., Ltd
  • Dabur
  • Dali Foods Group Co., Ltd
  • Danone
  • Dr. Pepper Snapple Group
  • Eko Vit Sp zoo
  • Fonterra Co-operative Group
  • Hangzhou Wahaha Group Co., Ltd
  • HUL
  • Kraft Heinz Company
  • Mondelez International Inc.
  • Monster Beverage Corporation
  • Nestle S.A
  • Nongfu Spring
  • Otsuka Holdings Co Ltd
  • PepsiCo Inc.
  • Red Bull GmbH
  • Red Devil NV
  • Rockstar Inc
  • Shenzhen Eastroc Beverage Industrial Co., Ltd
  • South Beach Beverage Co. Inc.
  • Suntory Beverage & Food Ltd
  • The Cloud 9 Energy Drink
  • The Coca-Cola Company
  • The Hain Celestial Group
  • The Kraft Heinz Company
  • WNWM Ustronianka

For more information about this report visit https://www.researchandmarkets.com/r/f360ck

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Philly produce market fights to serve the community while facing hardship

Philly produce market fights to serve the community while facing hardship

  • January 4, 2021
PHILADELPHIA (WPVI) — West Phillie Produce has been a beacon of hope along 62nd Street near Market for 12 years. The community comes for fresh produce in an area that’s a food desert.

This small business says it desperately needs more funding to keep its doors open.

“West Phillie produce does a lot for the community. They help a lot of children out, they keep us fed,” Derrick Tate, a longtime customer said.

Even during the pandemic, West Phillie Produce remains open seven days a week.

COVID restrictions: Here’s what’s allowed to reopen in Philadelphia

But the owner was forced to lay off employees at a time when the black community needs fresh produce the most.

“Especially during these COVID-19 times, fruits and vegetables help boost the immune system. It’s very important for your underserved communities to have it ready, available and affordable,” owner Arnett Woodall said.

West Phillie Produce received a $5,000 Merchants Fund grant from the city, which helps businesses facing hardships. But they’re still waiting for federal funds like PPP, the Paycheck Protection Program, to come through.

“Open now 12 years now, seven days a week serving the community. We deserve more help than what we receive and we know that,” Woodall said.

The owner is also a member of the African American Chamber of Commerce and he says too many black-owned businesses like his are on the brink of shutting down.

“The trickle-down theory that we’ve operating on is not trickling down to our small businesses, to our underserved communities,” Woodall said.

The African American Chamber of Commerce says 75 percent of black-owned businesses were forced to shutdown for months, and many – like West Phillie Produce – are having difficulty with government assistance because of the application process or meeting qualifications.

West Phillie Produce, a lifeline, always willing to help those in need. Now, this business needs some help.

Copyright © 2021 WPVI-TV. All Rights Reserved.

Global Immuno-Oncology Drugs Market Report 2020-2030: COVID-19 Growth, Impact and Changes - ResearchAndMarkets.com | Business

Global Enzymes Market Analysis 2020-2030: COVID-19 Growth and Change – ResearchAndMarkets.com | Business

  • December 31, 2020

DUBLIN–(BUSINESS WIRE)–Dec 31, 2020–

The “Enzymes Global Market Report 2020-30: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com‘s offering.

The global enzymes market is expected to decline from $7.98 billion in 2019 to $7.81 billion in 2020 at a compound annual growth rate (CAGR) of -2.20%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $11.92 billion in 2023 at a CAGR of 15.15%.

The enzymes market consists of sales of enzymes to treat diseases. An enzyme is a protein or RNA formed by living cells that are extremely specific to its substrates and highly catalytic. Enzymes constitute a very significant class of biological macromolecular catalysts. Enzymes that are used in medical applications in their isolated or conjugated form with other drugs or therapies are known as therapeutic enzymes. Therapeutic enzymes are used in the treatment of various diseases including cancer, inflammatory disorders, cardiovascular diseases, and pain management.

North America was the largest region in the enzymes market in 2019.

In May 2020, AbbVie Inc., a US-based biopharmaceutical company, acquired Allergan plc for $63 billion. This acquisition significantly expands and diversifies AbbVie’s revenue base and complements existing leadership positions in Immunology, with Humira and recently launched Skyrizi and Rinvoq, and Hematologic Oncology, with Imbruvica and Venclexta. Allergan plc is an Ireland-based pharmaceutical company engaged in the research, development, and manufacture of pharmaceutical and enzymes-based therapeutic products.

The enzymes market covered in this report is segmented by product type into asparaginase; lipase; protease; nattokinase; chitinase; serratiopeptidase; collagenase; ligase; others and by application into leukemia; stomach disorders; antitumor; skin ulcers; gaucher disease; fabry disease; others.

The development of new approaches to treat cancer using enzymes is a key trend gaining popularity in the enzymes market. Major universities and companies are investing in researches focusing on evolving new solutions in enzyme therapies for cancer treatment. For example, in August 2018, Kyn Therapeutics, a US-based company that focuses on improving outcomes for cancer patients, along with the Cancer Prevention and Research Institute of Texas and the American Cancer Society funded the research introducing a new approach to cancer care using enzyme therapy to boost the immune system and fight back. The enzyme, PEG-KYNase, does not destroy cancer cells specifically but rather enables the immune system itself to remove unwanted cells. PEG-KYNase is designed to degrade the metabolite produced by numerous tumors known as kynurenine, which suppresses the immune system.

The growing prevalence of cancer and the need for drug-metabolizing enzymes (DMEs) for chemotherapy are expected to drive the growth of the enzymes market in the coming years. The activation of enzymes in a human body help destroy the cancer cells and breaks down the tumor. The expression and function of DMEs in cancer patients’ tumor tissues and metabolic organs is therefore essential and help patients for whom reaction to anticancer drugs and response to chemotherapy is low. According to the World Health Organization (WHO), 9.6 million deaths occurred in 2018 due to cancer and about 70% of deaths from cancer occur in low- and middle-income countries. Therefore, the increasing prevalence of cancer, which can be cured using therapeutic enzymes, is predicted to drive the growth of the enzymes market.

Scope of the report:

Markets Covered:

1) By Product Type: Asparaginase; Lipase; Protease; Nattokinase; Chitinase; Serratiopeptidase; Collagenase; Ligase; Others

2) By Application: Leukemia; Stomach Disorders; Antitumor; Skin Ulcers; Gaucher Disease; Fabry Disease; Others

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Companies Mentioned

  • Sanofi
  • AbbVie Inc.
  • Alexion Pharmaceuticals Inc
  • Horizon Pharma
  • Allergan plc
  • Pfizer Inc.
  • Vivus
  • Digestive Care
  • Leadiant Biosciences
  • Roche Holdings AG
  • Codexis Inc

For more information about this report visit https://www.researchandmarkets.com/r/mq1vlz

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com:https://www.businesswire.com/news/home/20201231005108/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/31/2020 07:51 AM/DISC: 12/31/2020 07:52 AM

http://www.businesswire.com/news/home/20201231005108/en

Copyright Business Wire 2020.

Global Immuno-Oncology Drugs Market Report 2020-2030: COVID-19 Growth, Impact and Changes - ResearchAndMarkets.com | Business

Global Immuno-Oncology Drugs Market Report 2020-2030: COVID-19 Growth, Impact and Changes – ResearchAndMarkets.com | Business

  • December 30, 2020

DUBLIN–(BUSINESS WIRE)–Dec 30, 2020–

The “Immuno-Oncology Drugs Global Market Report 2020-30: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com‘s offering.

Immuno-Oncology Drugs Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global immuno-oncology drugs market.

Major players in the immuno-oncology drugs market are Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb, Celgene Corporation, Eli Lilly and Company, Merck & Co., F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis International AG, and AbbVie Inc.

The global immuno-oncology drugs market is expected to decline from $59.64 billion in 2019 to $57.34 billion in 2020 at a compound annual growth rate (CAGR) of -3.86%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $80.11 billion in 2023 at a CAGR of 11.79%.

The immuno-oncology drugs market consists of sales of immuno-oncology drugs used for the treatment of cancer and related services by entities (organizations, sole traders and partnerships) that produce immuno-oncology drugs for cancer treatment. Immuno-oncology is the artificial stimulation of the immune system to treat cancer, improving the immune system’s ability to fight the disease. The market consists of revenue generated by the companies manufacturing immuno-oncology drugs by the sales of these products.

North America was the largest region in the immuno-oncology drugs market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

In December 2019, Sanofi, a Paris-based biopharmaceutical company, acquired Synthorx, Inc. for $2.5 billion. This acquisition is expected to allow Sanofi to gain access to Synthorx’s immuno-oncology drug candidate IL-2 therapeutics for solid tumors along with its expanded genetic alphabet platform. This builds a portfolio of high-quality assets for Sanofi to lead with innovation in the oncology market. Synthorx, Inc. is a US-based clinical-stage biotechnology company focused on cancer and autoimmune disorders.

The immuno-oncology drugs market covered in the report is segmented by type into monoclonal antibodies; immune checkpoint inhibitors; immune system modulators; cancer vaccines; others, by therapeutic application into melanoma; lung cancer; blood cancer; renal cell carcinoma; prostate cancer; bladder cancer; others, and by end-user into hospitals; clinics; ambulatory surgical centers; cancer research institutes.

The high cost of immuno-oncology therapies is a key factor hampering the growth of the market. The immunotherapy drugs cost more than the other cancer drugs and people who need immunotherapy for cancer, too often are not able to afford it. High costs associated with drugs is a major issue faced by patients across the globe. The pressure to contain costs and demonstrate value is widespread. In less wealthy countries, the lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy.

Companies in the immuno-oncology drugs market are increasing their product innovation through strategic collaborations. To sustain in the increasingly competitive immuno-oncology drugs market, companies are developing innovative products as well as sharing skills and expertise with other companies. While companies have long collaborated with each other as well as with academic and research institutions in this market by way of partnerships, and in- or out-licensing deals, this trend has been increasing over the recent years.

In 2019, Takeda announced its decision to accelerate the discovery of next-generation cancer immunotherapies, through collaborations. The company will collaborate with Memorial Sloan Kettering Cancer Center (MSK) to discover and develop novel chimeric antigen receptor T-cell (CAR-T) products for the treatment of multiple myeloma, acute myeloid leukemia and additional solid tumor indications.

The rise in the number of cancer cases across the globe is likely to contribute to the growth of the immune-oncology drugs market. According to the American Cancer Society, there were 1.7 million new cases and 0.6 million cancer deaths in 2019 in the USA. The four most common types of cancers worldwide are lung, prostate, bowel, and female breast cancer, accounting for 43% of the new cancer cases. Therefore, the rise in cancer incidence rate globally is anticipated to boost the demand for the immune-oncology drugs market over the coming years.

Companies Mentioned

  • Amgen, Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Eli Lilly and Company
  • Merck & Co.
  • F. Hoffmann-La Roche AG
  • Johnson & Johnson
  • Novartis International AG
  • AbbVie, Inc.
  • Pfizer Inc
  • Sanofi S.A.
  • Incyte
  • EMD Serono, Inc.
  • Gilead Sciences Inc.
  • Prometheus Therapeutics & Diagnostics
  • Aduro BioTech
  • Galena Biopharma
  • Bavarian Nordic
  • Celldex Therapeutics
  • ImmunoCellular Therapeutics
  • Takeda
  • Spectrum Pharmaceuticals
  • GlaxoSmithKline
  • Janssen Biotech

For more information about this report visit https://www.researchandmarkets.com/r/vu5r31

View source version on businesswire.com:https://www.businesswire.com/news/home/20201230005147/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: GENERAL HEALTH PHARMACEUTICAL HEALTH ONCOLOGY

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 12/30/2020 07:27 AM/DISC: 12/30/2020 07:27 AM

http://www.businesswire.com/news/home/20201230005147/en

Copyright Business Wire 2020.

Global Enzymes Market Outlook to 2030

Global Enzymes Market Outlook to 2030

  • December 24, 2020

Dublin, Dec. 24, 2020 (GLOBE NEWSWIRE) — The “Enzymes Global Market Report 2020-30: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com’s offering.

The global enzymes market is expected to decline from $7.98 billion in 2019 to $7.81 billion in 2020 at a compound annual growth rate (CAGR) of -2.20%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $11.92 billion in 2023 at a CAGR of 15.15%.

The enzymes market consists of sales of enzymes to treat diseases. An enzyme is a protein or RNA formed by living cells that are extremely specific to its substrates and highly catalytic. Enzymes constitute a very significant class of biological macromolecular catalysts. Enzymes that are used in medical applications in their isolated or conjugated form with other drugs or therapies are known as therapeutic enzymes. Therapeutic enzymes are used in the treatment of various diseases including cancer, inflammatory disorders, cardiovascular diseases, and pain management.

North America was the largest region in the enzymes market in 2019.

In May 2020, AbbVie Inc., a US-based biopharmaceutical company, acquired Allergan plc for $63 billion. This acquisition significantly expands and diversifies AbbVie’s revenue base and complements existing leadership positions in Immunology, with Humira and recently launched Skyrizi and Rinvoq, and Hematologic Oncology, with Imbruvica and Venclexta. Allergan plc is an Ireland-based pharmaceutical company engaged in the research, development, and manufacture of pharmaceutical and enzymes-based therapeutic products.

The enzymes market covered in this report is segmented by product type into asparaginase; lipase; protease; nattokinase; chitinase; serratiopeptidase; collagenase; ligase; others and by application into leukemia; stomach disorders; antitumor; skin ulcers; gaucher disease; fabry disease; others.

The development of new approaches to treat cancer using enzymes is a key trend gaining popularity in the enzymes market. Major universities and companies are investing in researches focusing on evolving new solutions in enzyme therapies for cancer treatment. For example, in August 2018, Kyn Therapeutics, a US-based company that focuses on improving outcomes for cancer patients, along with the Cancer Prevention and Research Institute of Texas and the American Cancer Society funded the research introducing a new approach to cancer care using enzyme therapy to boost the immune system and fight back. The enzyme, PEG-KYNase, does not destroy cancer cells specifically but rather enables the immune system itself to remove unwanted cells. PEG-KYNase is designed to degrade the metabolite produced by numerous tumors known as kynurenine, which suppresses the immune system.

The growing prevalence of cancer and the need for drug-metabolizing enzymes (DMEs) for chemotherapy are expected to drive the growth of the enzymes market in the coming years. The activation of enzymes in a human body help destroy the cancer cells and breaks down the tumor. The expression and function of DMEs in cancer patients’ tumor tissues and metabolic organs is therefore essential and help patients for whom reaction to anticancer drugs and response to chemotherapy is low. According to the World Health Organization (WHO), 9.6 million deaths occurred in 2018 due to cancer and about 70% of deaths from cancer occur in low- and middle-income countries. Therefore, the increasing prevalence of cancer, which can be cured using therapeutic enzymes, is predicted to drive the growth of the enzymes market.

Scope of the report:

Markets Covered:
1) By Product Type: Asparaginase; Lipase; Protease; Nattokinase; Chitinase; Serratiopeptidase; Collagenase; Ligase; Others
2) By Application: Leukemia; Stomach Disorders; Antitumor; Skin Ulcers; Gaucher Disease; Fabry Disease; Others

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: Country and regional historic and forecast data, market share of competitors, market segments.

Companies Mentioned

  • Sanofi
  • AbbVie Inc.
  • Alexion Pharmaceuticals Inc
  • Horizon Pharma
  • Allergan plc
  • Pfizer Inc.
  • Vivus
  • Digestive Care
  • Leadiant Biosciences
  • Roche Holdings AG
  • Codexis Inc

For more information about this report visit https://www.researchandmarkets.com/r/obe9i6

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Highest-Dose Immune Supplement on Market Launched by Healthycell

Highest-Dose Immune Supplement on Market Launched by Healthycell

  • December 15, 2020

IMMUNE SUPER BOOST helps boost defense with an immunity-supercharging blend of phytonutrients, including Echinacea and Elderberry, plus vitamins and minerals that support white blood cell count, activate immune cells, promote healthy immune response, and support immune system regulation.†

“The problem with most multi-ingredient immune supplements is that they don’t provide the effective doses shown by clinical studies to impact immunity,” commented Healthycell CEO Douglas Giampapa. “Our product holds 25 mL of nutrients in one gel pack, making it easier to provide our customers with effective doses. IMMUNE SUPER BOOST has over 9,750 mg of nutrients in each gel pack, so people don’t have to buy various bottles of different supplements to reach effective doses.”

Formulated by an expert team of physicians and nutritionists, IMMUNE SUPER BOOST contains effective doses of vitamin C, vitamin D3, zinc, Echinacea extract, and Elderberry extract to support immunity. It also includes other nutrients linked to immune support, such as beta-glucan, citrus pectin, polyphenols, flavonoids, vitamin E, and vitamin B6.

With a great-tasting natural blackberry flavor, IMMUNE SUPER BOOST is a uniquely functional and delicious gel that can be enjoyed conveniently straight from the pack, mixed in water, or added to smoothies.

Healthycell uses only cruelty-free, sustainably-harvested ingredients, and packaging that is 100% recyclable. Product boxes are recyclable through municipal programs, and Healthycell is partnered with TerraCycle so customers can send back their empty gel packs to be recycled free of charge.

To learn more, visit healthycell.com, Twitter, Facebook, and Instagram.

About Healthycell 

About MICROGEL™ 

 These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

SOURCE Healthycell

Related Links

https://www.healthycell.com

Innova Market Insights spotlights immunity offerings for beverages, cereals and dairy

Innova Market Insights spotlights immunity offerings for beverages, cereals and dairy

  • December 10, 2020


09 December 2020 — Consumer appetite for health-fortifying offerings has risen over the last year and has been accelerated by the ongoing COVID-19 pandemic. “In Tune with Immune” is now pegged as one of Innova Market InsightsTop Trends for 2021, reflecting how immunity and health will steer the development of functional ingredients in the coming years.

“Beyond established segments for immune health NPD, like supplements, baby food and sports nutrition, product innovation has expanded its horizon into more mainstream product categories according to the Innova Database,” Chang Liu, market analyst at Innova Market Insights, tells FoodIngredientsFirst.

“Some examples include beverages, cereals and dairy. We have tracked such products highlighting ingredients like botanicals, vitamins, minerals and probiotics with functions including boosting the immune system and supporting defense.

Click to EnlargeIn the realm of digestive and gut health, the link is also increasingly being made between probiotics, prebiotics and immune support.According to Innova’s Consumer Survey 2020, six out of ten global consumers are increasingly looking for F&B products that support their immune health, with one in three saying that concerns about immune health increased in 2020 over 2019.

“Immunity-boosting ingredients will play a significant role for the coming year, while research and interest in the role of the microbiome and personalized nutrition as ways to strengthen immunity will accelerate,” details Lu Ann Williams, global insights director at Innova Market Insights.

More than half of consumers are gaining label literacy
Innova Market Insights research also indicated that 54 percent of global consumers claimed to have spent time educating themselves on ingredients and procedures that could boost their immune health in the wake of concerns over COVID-19. 

As might be expected in the light of this, the use of immune health positionings for food and drinks is rising, with 1.7 percent of global launches over the first ten months of 2020 using this type of claim, up from just 1 percent five years previously.

“According to the Innova Database, 16 percent of global F&B new product launches tracked in 2019 with active health claims are related to immune health,” remarks Liu. 

“New product innovation featuring immune benefits also has witnessed an annual average growth of 16 percent from 2015 to 2019.”

Also prominent was getting enough sleep for good health, which has inspired relevant NPD over the last year. Examples include myAir’s personalized nutrition bars, which use adaptogens and plant-based ingredients to address stress. Meanwhile, PepsiCo’s Driftwell drink features L-Theanine and magnesium to help consumers wind down before bedtime.

Fortifying the microbiome with functional food
The link is also increasingly being made between probiotics, prebiotics and immune support. Consumer awareness of the benefits of probiotics is still gaining traction, with its relationship to gut health and a strong immune system increasingly being made clear.

“More than a third of F&B launches tracked with immune health claims are related to digestive/gut health. Probiotics and prebiotics are the highlighted ingredients when it comes to gut health,” says Liu.

“We do see the diversification and fragmentation of probiotic ingredients being applied in products featuring gut health benefits. For instance, there is a 79 percent of growth for F&B and supplement products with Lactobacillus reuteri from 2015 to 2019 on the global level,” she continues.

“With ongoing research and technology breakthrough, we expect more types of probiotics and prebiotics to be applied for gut health.”

Prebiotics have generally been slower to establish themselves in the consumer consciousness; although they have been around for many years, it is only relatively recently that they have started to move into the mainstream. 

Innova Market Insights also reports a 20 percent global growth for food and beverage launches with prebiotics in 2018 over 2017 and a further rise of over 13 percent for 2019. 

Often used in combination with probiotics, prebiotics are featured across a range of food and drinks launches, led by baby & toddler products, ahead of soft drinks and dairy products.

By Benjamin Ferrer


To contact our editorial team please email us at
editorial@cnsmedia.com


If you found this article valuable, you may wish to receive our newsletters.

Subscribe now to receive the latest news directly into your inbox.

Global Immunity Boosting Food Products Market Report 2020-2030 with COVID-19 Implications and Growth Insights - ResearchAndMarkets.com

Global Immunity Boosting Food Products Market Report 2020-2030 with COVID-19 Implications and Growth Insights – ResearchAndMarkets.com

  • December 9, 2020

DUBLIN–()–The “Immunity Boosting Food Products Global Market Report 2020-30: COVID-19 Implications and Growth” report has been added to ResearchAndMarkets.com’s offering.

The global immunity boosting food products market is expected to grow from $16.31 billion in 2019 to $22.76 billion in 2020 at a compound annual growth rate (CAGR) of 39.6%. The exponential growth is mainly due to the outbreak of COVID-19 that raised awareness about boosting immunity in the human body to protect from being infected by the virus. The market is then expected to reach $24.02 billion in 2023 at a CAGR of 1.81%.

This report focuses on immunity boosting food products market which is experiencing strong growth. The report gives a guide to the immunity boosting food products market which will be shaping a

Major players in the immunity boosting food products market are Danone SA, Nestle S.A., Blue Diamond Growers, Diamond Foods, LLC., Dole Food Company, Inc., Pinnacle Foods Corp., Olam International, Hines Nut Company, Fonterra Group Cooperative Limited, and Associated British Foods PLC.

The immunity boosting food products market consists of sales of food products used to boost the immune system. The market consists of revenues generated by sales of immunity-boosting food products by companies producing them.

North America was the largest region in the immunity boosting food products market in 2019. Asia Pacific is expected to be the fastest-growing region in the immunity boosting food products market in the forecast period.

In 2019, Olam International, a major food and agri-business company acquired Hughson Nut Inc., (HNI) from APB Partners, L.L.C. for $54 million. The acquisition of HNI is consistent with Olam’s strategic plan to offer differentiated solutions such as ingredients and product innovation and to target new customer segments in co-manufacturing, foodservice and e-commerce. Hughson Nut is a grower, buyer and processor of California almonds.

The immunity boosting food products market covered in this report is segmented by product type into herbs & spices; nuts & seeds; fruits & vegetables; dairy-based products; probiotics and prebiotics; others. It is also segmented by form into tablets; capsules; powder; liquid; others and by distribution channel into store-based; non-store-based.

The high cost of raw materials and lack of awareness among people about the benefits of the products are hampering the growth of the immunity-boosting food products market. Nutrition care, which is an essential element of preventive health care, is simultaneously experiencing a major evolution in highly populous countries like India. There is a lack of awareness about the immunity boosting food products in a swiftly growing middle-class population. On the other hand, the high cost of raw materials used in the manufacturing of immunity-boosting food products has a great impact on the price of the final product, which may render them a practical option only for the urban and rich population, thereby limiting the market growth.

Instant immunity booster products are increasingly being used to boost immune function, which is used when under stress in the modern world. For instance, in January 2020, ZAND, the natural lozenge brand in health food stores known for herbal-based immune support, has launched the first rapid immunity product, Immune Fast. This breakthrough new supplement delivers clinically supported immune support whenever and wherever at work, the airport, school, large gatherings, anywhere. Thus, it is used on the spot to boost the immune system within two hours.

The increasing consciousness about health and fitness to live a healthier lifestyle will drive the immunity-boosting food products market. According to the Global Wellness Institute, in 2018, the global wellness market was valued at $4.5 trillion. According to the IHRSA (International Health, Racquet & Sportsclub Association), the health and fitness industry in the U.S. was valued at $30 billion in 2018. It has been growing by at least 3-4% annually for the last ten years.

Key Topics Covered:

1. Executive Summary

2. Immunity Boosting Food Products Market Characteristics

3. Immunity Boosting Food Products Market Size and Growth

3.1. Global Immunity Boosting Food Products Historic Market, 2015 – 2019, $ Billion

3.1.1. Drivers of the Market

3.1.2. Restraints on the Market

3.2. Global Immunity Boosting Food Products Forecast Market, 2019 – 2023F, 2025F, 2030F, $ Billion

3.2.1. Drivers of the Market

3.2.2. Restraints on the Market

4. Immunity Boosting Food Products Market Segmentation

4.1. Global Immunity Boosting Food Products Market, Segmentation by Product Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

  • Herbs & Spices
  • Nuts & Seeds
  • Fruits & Vegetables
  • Dairy-Based Products
  • Probiotics and Prebiotics
  • Others

4.2. Global Immunity Boosting Food Products Market, Segmentation by Form, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

  • Tablets
  • Capsules
  • Powder
  • Liquid
  • Others

4.3. Global Immunity Boosting Food Products Market, Segmentation by Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

  • Store-Based
  • Non-Store-Based

5. Immunity Boosting Food Products Market Regional and Country Analysis

5.1. Global Immunity Boosting Food Products Market, Split by Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

5.2. Global Immunity Boosting Food Products Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Companies Mentioned

  • Danone SA
  • Nestle S.A
  • Blue Diamond Growers
  • Diamond Foods, LLC.
  • Dole Food Company, Inc.
  • Pinnacle Foods Corp.
  • Olam International
  • Hines Nut Company
  • Fonterra group Cooperative Limited
  • Associated British Foods PLC

For more information about this report visit https://www.researchandmarkets.com/r/3nomki

The South Jersey MS Center Is Committed To Supporting Their Patients Throughout The COVID-19 Pandemic

India Immunity Boosting Packaged Products Markets Report 2020: Market is Projected to Reach $347 Million by 2026

  • December 7, 2020

DUBLIN, Dec. 7, 2020 /PRNewswire/ — The “India Immunity Boosting Packaged Products Market, by Product Category (Supplements, Beverages, Food and Others), by Distribution Channel (Convenience Stores, Specialty Stores, Others), by Region, Competition, Forecast & Opportunities, FY2026” report has been added to ResearchAndMarkets.com’s offering.

Research and Markets Logo

The Indian Immunity Boosting Packaged Products Market is projected to reach $ 347 million by FY 2026 owing to increasing consciousness and focus among Indian consumers towards preventive health.

Further, rising per capita income and expanding middle-class and urban population are some of the key factors fueling the growth of immunity boosting packaged products market. Increasingly busy lifestyle is resulting in a lack of nutrition and fitness among people, which is creating a huge demand for immunity boosting packaged products across the country.

The recent outbreak of COVID-19 has created a growing need for products which boost the body’s immune system. Apart from that, rising prevalence of various chronic diseases like diabetes and cancer are also driving the growth of immunity boosting packaged products market in the country. The soaring healthcare costs and rising consumer focus on preventive healthcare are expected to further augment the market growth in the coming years.

The Indian Immunity Boosting Packaged Products Market is categorized based on product category, distribution channel and region. Based on the product category, the market is split into supplements, beverages, food, and others. The food segment is further divided into instant food, seeds, and others. The beverages segment is categorized into juice, tea, coffee, probiotic shots and others and the supplements segment is divided into mixes, capsules, and powder.

In India, the supplements segment held the largest market share in FY 2020 owing to easy product availability of trusted manufactures and proven health claims. However, the food segment is also expected to witness a healthy CAGR during the forecast period due to focus on preventive healthcare in the country and broad range of products offered by the manufactures.

Based on the distribution channel, the Indian Immunity Boosting Packaged Products Market is segmented into convenience stores, specialty stores, supermarkets & hypermarkets, medical stores and online. The convenience stores segment dominated the Indian market in FY2020 and is expected to grow substantially during the forecast period. However, the online segment exhibited significant growth in FY2020, especially during the spread of COVID-19.

Major players operating in the immunity boosting packaged products market include The Himalaya Drug Company, Dabur India Ltd., Patanjali Ayurved, Organic India Private Limited, Amway India Enterprise Private Limited and Herbalife India Private Limited, Baidyanath Ayurved Bhawan Pvt. Ltd, Kerala Ayurveda Ltd, Aeronutrix Sports Products Private Limited, TBOF Foods Ltd, and Del Monte India, among others.

Companies are focused on launching new products carrying all the essential nutrients as well as on strengthening distribution network to increase their market share in the country’s immunity boosting products market.

Years considered for this report:

  • Historical Years: FY2016 – FY2019
  • Base Year: FY2020
  • Estimated Year: FY2021
  • Forecast Period: FY2022- FY2026

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on India Immunity Boosting Packaged Products Market

4. Executive Summary

5. India Immunity Boosting Packaged Products Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Category (Supplements, Beverages, Food and Others)
5.2.2. By Distribution Channel (Offline (Convenience Stores, Specialty Stores, Supermarkets & Hypermarkets, Medical Stores), Online)
5.2.3. By Region (North, East, South, West)
5.2.4. By Company (FY2020)
5.3. Market Attractiveness Index

6. India Immunity Boosting Supplements Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type (Mixes, Capsules, Powder)
6.2.2. By Distribution Channel (Offline (Convenience Stores, Specialty Stores, Supermarkets & Hypermarkets, Medical Stores), Online)

7. India Immunity Boosting Packaged Beverages Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type (Juice, Tea, Coffee, Probiotic Shots and Others (Syrup, etc.,))
7.2.2. By Distribution Channel (Offline (Convenience Stores, Specialty Stores, Supermarkets & Hypermarkets, Medical Stores), Online)

8. India Immunity Boosting Packaged Foods Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type (Instant Food, Seeds, and Others (Gummies etc.))
8.2.2. By Distribution Channel (Offline (Convenience Stores, Specialty Stores, Supermarkets & Hypermarkets, Medical Stores), Online)

9. India Immunity Boosting Others Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Distribution Channel (Offline (Convenience Stores, Specialty Stores, Supermarkets & Hypermarkets, Medical Stores), Online)

10. Market Dynamics
10.1. Drivers
10.2. Challenges

11. Market Trends & Developments

12. Pricing Analysis

13. Competitive Landscape
13.1. Players Profiled (Leading Companies)
13.1.1. Dabur India Limited
13.1.2. Patanjali Ayurved
13.1.3. The Himalaya Drug Company
13.1.4. Amway India Enterprises Pvt. Ltd.
13.1.5. Baidyanath Ayurved Bhawan Pvt. Ltd
13.1.6. Organic India Pvt. Ltd
13.1.7. Kerala Ayurveda Ltd
13.1.8. Aeronutrix Sports Products Private Limited
13.1.9. TBOF Foods Ltd.
13.1.10. Del Monte India

14. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/1erpz0

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/india-immunity-boosting-packaged-products-markets-report-2020-market-is-projected-to-reach-347-million-by-2026-301187233.html

SOURCE Research and Markets

Do NOT follow this link or you will be banned from the site!